Federal award
ON DEMAND PHARMACEUTICALS INC.
HR00111620029
Assistance
Obligated and Ceiling
- Obligated (net)
- $63,273,730.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $63,273,730.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ON DEMAND PHARMACEUTICALS INC. · SN3RFJHJ2GP3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 97AE · office HR0011
- Funding agency
- Department of Defense · sub-agency 97AE
- Assistance listing (CFDA)
- CFDA 12.910
- FAIN
- HR00111620029
- Award type code
- 05
- Actions
- 17 · Jun 20, 2016 to Nov 14, 2022
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History17
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Nov 14, 2022 | FY2023 | P00016 | B1 | $0.00 | — |
| Apr 20, 2022 | FY2022 | P00014 | B1 | $11,000,000.00 | — |
| Apr 20, 2022 | FY2022 | P00015 | EX | $0.00 | — |
| May 11, 2021 | FY2021 | P00013 | B1 | $0.00 | — |
| Feb 18, 2021 | FY2021 | P00012 | B1 | $0.00 | — |
| Sep 28, 2020 | FY2020 | P00011 | B1 | $20,000,000.00 | — |
| May 29, 2020 | FY2020 | P00010 | B1 | $23,856,409.00 | — |
| Apr 6, 2020 | FY2020 | P00009 | B1 | $600,913.00 | — |
| Feb 6, 2020 | FY2020 | P00008 | B1 | $1,096,864.00 | — |
| May 9, 2019 | FY2019 | P00007 | B1 | $1,538,000.00 | — |
| Sep 25, 2018 | FY2018 | P00006 | B1 | $1,377,000.00 | — |
| Dec 1, 2017 | FY2018 | P00005 | EX | $90,000.00 | — |
| Apr 26, 2017 | FY2017 | P00004 | B1 | $31,640.00 | — |
| Apr 26, 2017 | FY2017 | P00003 | B1 | $1,349,989.00 | — |
| Feb 10, 2017 | FY2017 | 0002 | B1 | $246,558.00 | — |
| Dec 12, 2016 | FY2017 | 0001 | B1 | $158,688.00 | — |
| Jun 20, 2016 | FY2016 | — | A1 | $1,927,669.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.